Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monoamine transporters (MATs) are integral membrane proteins responsible for the reuptake of monoamine neurotransmitters—dopamine, serotonin, and norepinephrine—from the synaptic cleft back into presynaptic neurons. This process is essential for terminating neurotransmitter signaling and maintaining neurotransmitter homeostasis in the central nervous system. They are critical targets for many drugs including antidepressants (SSRIs/SNRIs), psychostimulants like cocaine/amphetamine, as well as being implicated in neuropsychiatric disorders such as depression or ADHD.
Inhibition of monoamine reuptake
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monoamine Transporter (MAT).